Creso Pharma Limited

ASX (AUD): Creso Pharma Limited (CPH)

Last Price

0.01

Today's Change

0.00 (0.00%)

Day's Change

0.01 - 0.011

Trading Volume

2,598,638

Overview

Market Cap

23 Million

Shares Outstanding

2 Billion

Avg Volume

10,010,226

Avg Price (50 Days)

0.01

Avg Price (200 Days)

0.02

PE Ratio

-0.45

EPS

-0.02

Earnings Announcement

29-Aug-2023

Previous Close

0.01

Open

0.01

Day's Range

0.009 - 0.009

Year Range

0.008 - 0.053

Trading Volume

919,691

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

0.00%

3 Month Change

0.00%

6 Month Change

-59.09%

Ytd Change

-55.00%

1 Year Change

-77.50%

3 Year Change

-70.00%

5 Year Change

-98.58%

10 Year Change

-96.54%

Max Change

-96.54%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment